Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
Allergic Reactions02:06

Allergic Reactions

Overview
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...
Cross-reactivity00:42

Cross-reactivity

Overview
Hypersensitivities01:30

Hypersensitivities

Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Baseline Descending Aortic Diameter Drives Long-Term Failure of Conservative Management in Uncomplicated Type B Aortic Dissection.

Annals of vascular surgery·2026
Same author

[Update on the assessment of the impact of occupational contact allergies in case of occupational skin disease no. 5101].

Dermatologie (Heidelberg, Germany)·2026
Same author

Addressing Endograft Infection After EVAR.

JACC. Case reports·2025
Same author

Understanding European patterns of deprescribing antithrombotic medication during end-of-life care in patients with cancer.

Thrombosis research·2024
Same author

The Use of Short Dilator Tip in Endovascular Branched Arch Repair: A Case Series.

Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists·2024
Same author

Mitochondrial topoisomerase I (Top1MT) prevents the onset of metabolic dysfunction-associated steatohepatitis (MASH) in mice.

bioRxiv : the preprint server for biology·2024
Same journal

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
Same journal

[Viral infections of the skin].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
Same journal

[Viral exanthems in children].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
Same journal

[Erratum to: Digital health applications and data protection].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
Same journal

[Virus-induced exanthems in returning travellers].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
Same journal

[Venous ulcus cruris-Surgical treatment].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
See all related articles

Related Experiment Video

Updated: Jun 27, 2026

A Mouse Ear Model for Allergic Contact Dermatitis Evaluation
08:02

A Mouse Ear Model for Allergic Contact Dermatitis Evaluation

Published on: March 24, 2023

[New contact allergens for patch testing. A phase-out-model?].

D Becker1

  • 1Hautklinik der Johannes-Gutenberg-Universität Mainz, Langenbeckstrasse 1, 55101, Mainz. becker@hautklinik.klinik.uni-mainz.de

Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete
|December 23, 2008
PubMed
Summary
This summary is machine-generated.

Updating patch test series is crucial for diagnosing allergic contact dermatitis. Current regulations hinder the integration of new sensitizers and impact diagnostic quality.

More Related Videos

Contact Hypersensitivity as a Murine Model of Allergic Contact Dermatitis
08:25

Contact Hypersensitivity as a Murine Model of Allergic Contact Dermatitis

Published on: September 26, 2022

Removal and Replacement of Endogenous Ligands from Lipid-Bound Proteins and Allergens
09:09

Removal and Replacement of Endogenous Ligands from Lipid-Bound Proteins and Allergens

Published on: February 24, 2021

Related Experiment Videos

Last Updated: Jun 27, 2026

A Mouse Ear Model for Allergic Contact Dermatitis Evaluation
08:02

A Mouse Ear Model for Allergic Contact Dermatitis Evaluation

Published on: March 24, 2023

Contact Hypersensitivity as a Murine Model of Allergic Contact Dermatitis
08:25

Contact Hypersensitivity as a Murine Model of Allergic Contact Dermatitis

Published on: September 26, 2022

Removal and Replacement of Endogenous Ligands from Lipid-Bound Proteins and Allergens
09:09

Removal and Replacement of Endogenous Ligands from Lipid-Bound Proteins and Allergens

Published on: February 24, 2021

Area of Science:

  • Dermatology
  • Allergology
  • Pharmacovigilance

Context:

  • The German Contact Dermatitis Research Group continuously updates patch test series for accurate allergic contact dermatitis diagnosis.
  • Recent revisions to the German Drug Registration and Administration Act equate patch test allergens with medications, creating regulatory hurdles.
  • Existing payment structures in the German Uniform Value Scale disconnect diagnostic fees from the number of tests performed.

Purpose:

  • To discuss the challenges in updating patch test series due to new regulations.
  • To present strategies for incorporating new contact sensitizers into routine testing.
  • To analyze the impact of current payment regulations on the quality of allergic contact dermatitis diagnosis.

Summary:

  • Current regulations under the German Drug Registration and Administration Act impede the practical application and registration of new contact sensitizers for patch testing.
  • The German Contact Dermatitis Research Group faces challenges in updating diagnostic tools due to these stringent regulations.
  • The fee structure for patch testing, disconnected from the number of tests, may compromise the diagnostic depth and overall quality.

Impact:

  • Regulatory barriers may delay the availability of essential diagnostic tools for allergic contact dermatitis.
  • The quality of dermatological diagnostics could be threatened by the current regulatory and financial landscape.
  • There is a need for revised strategies to ensure the continuous actualization of patch test series and maintain diagnostic standards.